Guy Nadler

Title: Guy Nadler: Innovator in Pharmaceutical Chemistry

Introduction

Guy Nadler is a notable inventor based in Saint Gregoire, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative compounds and derivatives. With a total of two patents to his name, Nadler's work has implications for various therapeutic applications.

Latest Patents

Nadler's latest patents include "Thiadiazinone, oxadiazinone and triazinone derivatives, and their use," which describes a compound of formula (I), or a pharmaceutically acceptable salt thereof. In this patent, R₁ can be hydrogen, lower alkyl, or CH₂OR₆. Another significant patent is "Aminoalkyl secocanthine derivatives and their use," which details a compound of formula (I) or a pharmaceutically acceptable salt thereof. In this case, R₁ is hydrogen, C₁-6 alkyl, C₁-6 alkoxy, or halogen, with various other substituents defined for R₂, R₃, R₄, R₅, R₆, R₇, R₈, and R₉.

Career Highlights

Throughout his career, Guy Nadler has worked with several prominent companies in the pharmaceutical industry. Notable among these are Laboratoires Sobio S.A. and Beecham-Wuelfing GmbH & Co. KG. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Nadler has collaborated with several professionals in his field, including Michel Martin and Richard Zimmermann. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Guy Nadler is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and collaborations. His contributions continue to influence the field and pave the way for future innovations.